Etiology and treatment of mood and anxiety disorders.
Risk factors for depression and anxiety disorders using measures of central and autonomic nervous system function - especially EEG, resting state fMRI connectivity, and cardiac vagal control.
Development of novel and neurally-informed treatments for mood and anxiety disorders - including transcranial focused ultrasound (tFUS) and psilocybin to address repetitive negative thinking.
The most recent work has focused specifically on two lines of work:
Investigating transcranial focused ultrasound as a neuromodulation approach to alter emotional well-being, with the ultimate aim to provide a novel treatment for depression and anxiety disorders.
Assessing the potential utility of guided psilocybin experience to alter brain network activity, and to improve symptoms and function in obsessive-compulsive disorder.
Joint appointments with Cognitive Science and Neuroscience
